Is printing out your own lab equipment, molecular models, and drug compounds the wave of the future?
Is printing out your own lab equipment, molecular models, and drug compounds the wave of the future?
Industry experts discuss the agency’s plans to make the drug approval process more transparent.
Much has changed in the 10 years since our first survey of industry researchers. Large companies are now looking to small, nimble ones for services as well as innovation.
The US Food and Drug Administration has relaxed some of the rules governing how companies must test the sterility of materials used to make biologic drugs.
The FDA is on board with a proposal to speed the approval of experimental pharmaceuticals that show big treatment effects early in clinical testing.
Researchers coax bacteria to produce tiny magnets and electrical wires that may be used to build advanced electronics.
The device could help grocers and food distributors better monitor fruits and vegetables.
The White House announces a strategy to foster development of biological products in fields ranging from medicine to agriculture.
George Rathmann, father of the biotech industry, passes away.